170 related articles for article (PubMed ID: 19701733)
1. [Scientific evidence and the cost of innovations in the health-care system].
Porzsolt F; Schreyögg J
Med Klin (Munich); 2009 Aug; 104(8):622-30. PubMed ID: 19701733
[TBL] [Abstract][Full Text] [Related]
2. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
3. The ethics of innovation: Columbus and others try something new.
McKneally MF
J Thorac Cardiovasc Surg; 2011 Apr; 141(4):863-6. PubMed ID: 21419897
[No Abstract] [Full Text] [Related]
4. [Rational therapy].
Weissbach L
Urologe A; 2000 May; 39(3):254-9. PubMed ID: 10872252
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of medical technologies: from theory to practice--the German perspective.
Graf von der Schulenburg JM
Soc Sci Med; 1997 Aug; 45(4):621-33. PubMed ID: 9226786
[TBL] [Abstract][Full Text] [Related]
6. [Prioritizing. What is the cause of the cost explosion in the health care system?].
Filous N
MMW Fortschr Med; 2010 Mar; 152(12):18. PubMed ID: 20397302
[No Abstract] [Full Text] [Related]
7. Managing healthcare costs within an integrated framework.
Fernandes R
Healthc Pap; 2002; 3(1):70-6; discussion 87-94. PubMed ID: 12811114
[TBL] [Abstract][Full Text] [Related]
8. [Practice guidelines in rehabilitation: infringement upon physicians' autonomy or foundation for better outcomes?].
Brüggemann S; Korsukéwitz C
Rehabilitation (Stuttg); 2004 Oct; 43(5):304-11. PubMed ID: 15472789
[TBL] [Abstract][Full Text] [Related]
9. Revolution then evolution: the advance of health economic evaluation in Australia.
Lopert R; Viney R
Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
[TBL] [Abstract][Full Text] [Related]
10. Early benefit assessment for pharmaceuticals in Germany: lessons for policymakers.
Schlette S; Hess R
Issue Brief (Commonw Fund); 2013 Oct; 29():1-9. PubMed ID: 24171232
[TBL] [Abstract][Full Text] [Related]
11. [Economics and ethics in public health?].
Blum R
Gesundheitswesen; 1999 Jan; 61(1):1-7. PubMed ID: 10081179
[TBL] [Abstract][Full Text] [Related]
12. [Resources for prevention?].
MMW Fortschr Med; 2006 Dec; 148(51-52):62-3. PubMed ID: 17619351
[No Abstract] [Full Text] [Related]
13. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
[TBL] [Abstract][Full Text] [Related]
14. [Unfairly implicated as cost drivers. New drugs without a chance?].
MMW Fortschr Med; 2004 Mar; 146(10):45. PubMed ID: 15347085
[No Abstract] [Full Text] [Related]
15. [Innovation or pseudo-innovation: that is the question].
Unger T
Med Klin (Munich); 2006 Mar; 101(3):257-62. PubMed ID: 16648986
[No Abstract] [Full Text] [Related]
16. Propaganda or the cost of innovation? Challenging the high price of new drugs.
Ghinea N; Lipworth W; Kerridge I
BMJ; 2016 Mar; 352():i1284. PubMed ID: 26968991
[No Abstract] [Full Text] [Related]
17. [Consequences of the German AMNOG for the identification of study objectives to demonstrate clinical efficacy and cost effectiveness of innovative drugs].
Götte D
Dtsch Med Wochenschr; 2012 Feb; 137(6):274-80. PubMed ID: 22270904
[TBL] [Abstract][Full Text] [Related]
18. [Advanced therapy medicinal products : Scientific, medical, economic, and ethical aspects].
Seitz R; Schneider CK; Hengel H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):789-90. PubMed ID: 21698529
[No Abstract] [Full Text] [Related]
19. [The costs of new drugs compared to current standard treatment].
Ujeyl M; Schlegel C; Gundert-Remy U
Z Evid Fortbild Qual Gesundhwes; 2013; 107(7):461-7. PubMed ID: 24238023
[TBL] [Abstract][Full Text] [Related]
20. [Declining costs].
Neumaier J
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
